{"id":1962,"date":"2026-04-17T08:49:48","date_gmt":"2026-04-17T08:49:48","guid":{"rendered":"https:\/\/www.anuhpharma.com\/investor-relations\/?post_type=investor-relation&#038;p=1962"},"modified":"2026-04-17T08:59:46","modified_gmt":"2026-04-17T08:59:46","slug":"reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2","status":"publish","type":"investor-relation","link":"https:\/\/www.anuhpharma.com\/investor-relations\/investor-relation\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\/","title":{"rendered":"Reconciliation of Share Capital Audit Report for the quarter ended 31st March, 2025"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":0,"menu_order":0,"template":"","meta":{"footnotes":""},"investor-relations-category":[25],"financial-year":[85],"class_list":["post-1962","investor-relation","type-investor-relation","status-publish","hentry","investor-relations-category-other-corporate-announcements","financial-year-2025-2026"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Reconciliation of Share Capital Audit Report for the quarter ended 31st March, 2025 - Anuh Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.anuhpharma.com\/investor-relations\/investor-relation\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Reconciliation of Share Capital Audit Report for the quarter ended 31st March, 2025 - Anuh Pharma\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.anuhpharma.com\/investor-relations\/investor-relation\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Anuh Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-17T08:59:46+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/investor-relation\\\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\\\/\",\"url\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/investor-relation\\\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\\\/\",\"name\":\"Reconciliation of Share Capital Audit Report for the quarter ended 31st March, 2025 - Anuh Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/#website\"},\"datePublished\":\"2026-04-17T08:49:48+00:00\",\"dateModified\":\"2026-04-17T08:59:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/investor-relation\\\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/investor-relation\\\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/investor-relation\\\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Investor Relations\",\"item\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investor Relations\",\"item\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/investor-relation\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Reconciliation of Share Capital Audit Report for the quarter ended 31st March, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/#website\",\"url\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/\",\"name\":\"Anuh Pharma\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/#organization\",\"name\":\"Anuh Pharma Limited\",\"url\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/anuh-pharma-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/anuh-pharma-logo.png\",\"width\":197,\"height\":71,\"caption\":\"Anuh Pharma Limited\"},\"image\":{\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/anuhpharma\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Reconciliation of Share Capital Audit Report for the quarter ended 31st March, 2025 - Anuh Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.anuhpharma.com\/investor-relations\/investor-relation\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\/","og_locale":"en_US","og_type":"article","og_title":"Reconciliation of Share Capital Audit Report for the quarter ended 31st March, 2025 - Anuh Pharma","og_url":"https:\/\/www.anuhpharma.com\/investor-relations\/investor-relation\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\/","og_site_name":"Anuh Pharma","article_modified_time":"2026-04-17T08:59:46+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.anuhpharma.com\/investor-relations\/investor-relation\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\/","url":"https:\/\/www.anuhpharma.com\/investor-relations\/investor-relation\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\/","name":"Reconciliation of Share Capital Audit Report for the quarter ended 31st March, 2025 - Anuh Pharma","isPartOf":{"@id":"https:\/\/www.anuhpharma.com\/investor-relations\/#website"},"datePublished":"2026-04-17T08:49:48+00:00","dateModified":"2026-04-17T08:59:46+00:00","breadcrumb":{"@id":"https:\/\/www.anuhpharma.com\/investor-relations\/investor-relation\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.anuhpharma.com\/investor-relations\/investor-relation\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.anuhpharma.com\/investor-relations\/investor-relation\/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2025-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Investor Relations","item":"https:\/\/www.anuhpharma.com\/investor-relations\/"},{"@type":"ListItem","position":2,"name":"Investor Relations","item":"https:\/\/www.anuhpharma.com\/investor-relations\/investor-relation\/"},{"@type":"ListItem","position":3,"name":"Reconciliation of Share Capital Audit Report for the quarter ended 31st March, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.anuhpharma.com\/investor-relations\/#website","url":"https:\/\/www.anuhpharma.com\/investor-relations\/","name":"Anuh Pharma","description":"","publisher":{"@id":"https:\/\/www.anuhpharma.com\/investor-relations\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.anuhpharma.com\/investor-relations\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.anuhpharma.com\/investor-relations\/#organization","name":"Anuh Pharma Limited","url":"https:\/\/www.anuhpharma.com\/investor-relations\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anuhpharma.com\/investor-relations\/#\/schema\/logo\/image\/","url":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-content\/uploads\/2024\/02\/anuh-pharma-logo.png","contentUrl":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-content\/uploads\/2024\/02\/anuh-pharma-logo.png","width":197,"height":71,"caption":"Anuh Pharma Limited"},"image":{"@id":"https:\/\/www.anuhpharma.com\/investor-relations\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/anuhpharma"]}]}},"_links":{"self":[{"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/investor-relation\/1962","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/investor-relation"}],"about":[{"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/types\/investor-relation"}],"version-history":[{"count":1,"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/investor-relation\/1962\/revisions"}],"predecessor-version":[{"id":1964,"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/investor-relation\/1962\/revisions\/1964"}],"wp:attachment":[{"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/media?parent=1962"}],"wp:term":[{"taxonomy":"investor-relations-category","embeddable":true,"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/investor-relations-category?post=1962"},{"taxonomy":"financial-year","embeddable":true,"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/financial-year?post=1962"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}